Grzegorz Goñda
Keine laufenden Positionen mehr
Profil
Mr. Grzegorz Goñda is on the Board of Directors at ERNE VENTURES SA.
Mr. Goñda was previously employed as an Analyst by KBC Securities NV.
Ehemalige bekannte Positionen von Grzegorz Goñda
| Unternehmen | Position | Ende |
|---|---|---|
| KBC Securities NV (Poland) | Analyst-Equity | 01.02.2005 |
| ERNE VENTURES SA | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Erne Ventures SA
 Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
| KBC Securities NV (Poland) | Finance |
